“The most exciting thing in 2025 was new data and its correlation with chemotherapeutic and immunotherapy delivery,“ John Oertle, chief medical director at Envita Medical Centers, told Inside Precision Medicine. Such advances should help generate responses in more patients and find more effective combinations. Envita has been delivering personalized cancer care for approximately 25 years.Key […]
